Urgent Palliative Care Medicines Cheshire West

The NHS Cheshire and Merseyside Integrated Care Board has completed a procurement process, awarding a contract for "Urgent Palliative Care Medicines Cheshire West" under a Provider Selection Regime (PSR). This contract commenced on 1st April 2025 and will expire on 31st March 2026. It was awarded using a limited procurement method without prior publication of a call for competition, in line with the Health Care Services (Provider Selection Regime) Regulations 2023.

The contract, valued at an estimated £1,816,20 annually for Cheshire West, enables local pharmacists to provide urgent palliative care medicines, ensuring that stock is available beyond the core holding. Suppliers involved include Rowlands Pharmacy and Well Pharmacy, located within Cheshire West. This tender offers significant opportunities for pharmacies interested in expanding their service offerings in health care.

Due to the urgent and often unpredictable demand for specific palliative care medicines, the awarded pharmacies are expected to manage consistent stock levels, even in instances where the medicines have low usage rates. The contract's requirement for enhanced stock management and the potential for quarterly reimbursements highlight opportunities for businesses skilled in inventory control and healthcare service delivery. Large-scale companies with a focus on pharmacy and health services are particularly well-suited to leverage this contract to extend their influence and operational footprint within the Cheshire West region.